IPOPLUS

51.48

-0.8 -1.53%

18 Jun 2026

NSE Listed · Pharmaceuticals

Morepen Lab. Ltd. (MOREPENLAB)

Volume: 7,10,949Avg Vol 1W: 12,46,324Avg Vol 1M: 6,72,69652W Range:33.0570.5
₹51.48 1.53%
Market Cap₹2,749 Cr
Current Price₹51.48
Previous Close₹52.28
High / Low (52w)₹70.5 / ₹33.05
Volume7,10,949
Avg Vol (1W)12,46,324
Avg Vol (1M)6,72,696
Stock P/E22.26
Book Value₹22.75
Dividend Yield0.4%
ROE5.96%
ROA4.94%
Revenue (TTM)
Revenue Growth7.17%
Profit Margin5.25%
Total Debt₹26 Cr
Shares Outstanding55 Cr
Face Value₹2
EPS (TTM)₹0.28
P/B2.01
Debt / Equity0.17
50 DMA₹44.04
200 DMA₹40.29
Day change-1.53%
Price Chart
51.48 5.49% · 1Y
583411.9Cr
2025-10-01
2026-06-16

20-day avg volume: 7.3L shares

Pros
  • Company is almost debt-free.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022Dec 2021Sept 2021Jun 2021Mar 2021Dec 2020Sept 2020Jun 2020Mar 2020
Revenue₹485 Cr₹484 Cr₹412 Cr₹425 Cr₹466 Cr₹453 Cr₹438 Cr₹455 Cr₹423 Cr₹445 Cr₹422 Cr₹401 Cr₹364 Cr₹348 Cr₹403 Cr₹302 Cr₹368 Cr₹397 Cr₹395 Cr₹387 Cr₹287 Cr₹307 Cr₹336 Cr₹258 Cr₹207 Cr
EBITDA₹27 Cr₹40 Cr₹24 Cr₹20 Cr₹30 Cr₹37 Cr₹47 Cr₹49 Cr₹43 Cr₹46 Cr₹29 Cr₹21 Cr₹12 Cr₹15 Cr₹23 Cr₹9 Cr₹15 Cr₹28 Cr₹38 Cr₹39 Cr₹28 Cr₹25 Cr₹28 Cr₹20 Cr₹12 Cr
Net Profit₹16 Cr₹28 Cr₹41 Cr₹11 Cr₹20 Cr₹27 Cr₹35 Cr₹36 Cr₹28 Cr₹32 Cr₹21 Cr₹15 Cr₹8 Cr₹9 Cr₹16 Cr₹6 Cr₹12 Cr₹22 Cr₹37 Cr₹30 Cr₹27 Cr₹24 Cr₹27 Cr₹19 Cr₹11 Cr
EPS0.280.50.750.20.350.490.650.710.540.630.420.290.160.160.330.110.240.410.720.590.590.530.60.430.25
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹1,830 Cr₹1,704 Cr₹1,424 Cr₹1,557 Cr₹1,200 Cr₹863 Cr
EBITDA₹163 Cr₹139 Cr₹58 Cr₹119 Cr₹100 Cr₹41 Cr
Net Profit₹118 Cr₹96 Cr₹39 Cr₹102 Cr₹97 Cr₹34 Cr
EPS2.21.880.771.962.150.75
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹1,778 Cr₹1,293 Cr₹1,110 Cr₹1,070 Cr₹858 Cr₹663 Cr
Total Liabilities₹591 Cr₹446 Cr₹358 Cr₹492 Cr₹434 Cr₹380 Cr
Equity₹1,187 Cr₹847 Cr₹752 Cr₹578 Cr₹424 Cr₹284 Cr
Total Debt₹26 Cr₹3 Cr₹1 Cr₹1 Cr₹1 Cr₹1 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Operating₹69 Cr₹111 Cr₹-75 Cr₹-35 Cr₹52 Cr₹17 Cr
Investing₹-322 Cr₹-83 Cr₹-47 Cr₹-32 Cr₹-70 Cr₹-12 Cr
Financing₹300 Cr₹5 Cr₹144 Cr₹66 Cr₹47 Cr₹5 Cr
Free Cash Flow₹69 Cr₹111 Cr₹-75 Cr₹-35 Cr₹52 Cr₹17 Cr
Shareholding
Promoter 35.65% Institutions 2.84% Public 61.5%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search